oral glp-1 for weight loss FDA UPDATE: A new medication has been approved 🚨 the first time, patients now have an FDA-approved oral option for medical management—expanding choices beyond injectable treatments. This breakthrough No nausea WLP-1 : GLP-1 Benefits, No
Description
Several studies have shown that tirzepatide reduces insulin resistance, improves glycemic control, and lowers inflammatory biomarkers, including C-reactive protein and IL-6 (46, 47)

However, cardiovascular outcomes are still widely debated and controversially evidenced
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
The only available study by Jensterle et al

The brain: quieting "food noise." GLP-1 receptors in the hypothalamus and reward centers reduce appetite and the intrusive thoughts about food that many patients with obesity describe
Regarding the implication of GLP-1RA in the process of protein folding, liraglutide has been shown to decrease MPTP-induced -syn aggregation in mice [86]
